BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15162529)

  • 41. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells.
    Hoffmann TK; Meidenbauer N; Dworacki G; Kanaya H; Whiteside TL
    Cancer Res; 2000 Jul; 60(13):3542-9. PubMed ID: 10910067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
    Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
    BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals.
    Forsberg O; Carlsson B; Malmström PU; Ullenhag G; Tötterman TH; Essand M
    Prostate; 2009 Jan; 69(1):70-81. PubMed ID: 18814178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G
    Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells].
    Lei CL; Huang CH; Yang Z; Tang XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):108-10. PubMed ID: 17653306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV].
    Fan CL; Chen HS; Li RB; Wang SX; Cong X; Fei R; Jiang D; Wang Y; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):67-71. PubMed ID: 14980100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
    Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.
    Kuznetsova M; Lopatnikova J; Khantakova J; Maksyutov R; Maksyutov A; Sennikov S
    BMC Immunol; 2017 Jun; 18(1):31. PubMed ID: 28633645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
    Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.
    Löhr HF; Krug S; Herr W; Weyer S; Schlaak J; Wölfel T; Gerken G; Meyer zum Büschenfelde KH
    Liver; 1998 Dec; 18(6):405-13. PubMed ID: 9869395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers.
    Xiong SQ; Lin BL; Gao X; Tang H; Wu CY
    Int Immunopharmacol; 2007 May; 7(5):578-87. PubMed ID: 17386405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.
    King TH; Kemmler CB; Guo Z; Mann D; Lu Y; Coeshott C; Gehring AJ; Bertoletti A; Ho ZZ; Delaney W; Gaggar A; Subramanian GM; McHutchison JG; Shrivastava S; Lee YJ; Kottilil S; Bellgrau D; Rodell T; Apelian D
    PLoS One; 2014; 9(7):e101904. PubMed ID: 25051027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells.
    Zarling AL; Johnson JG; Hoffman RW; Lee DR
    J Immunol; 1999 May; 162(9):5197-204. PubMed ID: 10227993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study of phenotypes and functions of cord blood dendritic cells from fetuses whose mothers had chronic hepatitis B].
    Zhang HH; Yang HX; Xi HL; He Y; Piao WH; Zhao H; Yu M; Wang GQ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):417-20. PubMed ID: 15975273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses.
    Hasebe A; Akbar SM; Furukawa S; Horiike N; Onji M
    Clin Exp Immunol; 2005 Jan; 139(1):35-42. PubMed ID: 15606611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.
    Ding CL; Yao K; Zhang TT; Zhou F; Xu L; Xu JY
    World J Gastroenterol; 2003 Jul; 9(7):1512-5. PubMed ID: 12854153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.